Try our Advanced Search for more refined results

September 10, 2014

In Re Copaxone 40 MG Consolidated Cases

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 21, 2017

    FDA Warning Wire: Pfizer Lapse Boosts Teva Blockbuster

    A newly disclosed warning letter to Pfizer is setting off a chain reaction that will likely delay a generic version of Teva's blockbuster Copaxone, one of the world's best-selling drugs. Here's a look at the remarkable development and other U.S. Food and Drug Administration warnings announced in recent days.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login